SCHEMBL4872250

SCHEMBL4872250

CC(C)(NO)C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 2/20 0.43
EPHX1 P07099 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
ALOX12 P18054 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
HSD17B10 Q99714 1/20 0.30
SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24761927 0.78 SSTR4 (0.41) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL14639632 0.78 SSTR4 (0.41) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL13682899 0.78 SSTR4 (0.41) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL26353635 0.78 SSTR4 (0.41) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL28159363 0.72 SSTR4 (0.38) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL10387220 0.72 EPHX1 (0.39) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL24049969 0.72 SSTR4 (0.42) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL28159316 0.72 SSTR4 (0.38) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL14454160 0.72 SSTR4 (0.42) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1
SCHEMBL15214543 0.72 SSTR4 (0.54) SSTR4EPHX1SMN1; SMN2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396959-B2 Process for preparing symmetrical and unsymmetrical N,N-dihydrocarbylhydroxylamines BASF SE (DE) 2008-07-08 US disclosed
US-20070129574-A1 Process for preparing symmetrical and unsymmetrical N,N-dihydrocarbylhydroxylamines BASF AKTIENGESELLSCHAFT (DE) 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129574-A1 Process for preparing symmetrical and unsymmetrical N,N-dihydrocarbylhydroxylamines HRH1, HRH3, HRH4 SSTR4 1360/4885EPHX1 641/4885SMN1; SMN2 4373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.